About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and related ...
A poll from the health policy nonprofit KFF found that 1 in 8 adults say they’ve taken a GLP-1 agonist, the obesity and ...
A KFF poll also suggests half of the respondents who had tried these weight loss meds no longer took them, with many ...
A wide swath of Americans are using GLP-1s despite shortages, a survey says. Meanwhile, Google DeepMind’s new AI model can ...
One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent ...
Other findings from the latest Kaiser Family Foundation Health Tracking Poll shed light on public awareness, use, and ...
Injected medications that treat diabetes and obesity increase the risk of a rare but serious side effect: stomach paralysis, ...
The new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that ...
The company plans to start assessing the effects of semaglutide, the active ingredient in Ozempic, and other medicines on ...
Nestlé, the maker of frozen food brands like Stouffer’s and DiGiorno, is slimming down with a new line of meals for people taking GLP-1 drugs for weight loss.
Drug Stocks latest news, photos, videos, breaking news, special reports, blogs, and updates from Business Insider India ...
Most users say they took the drug to treat a chronic condition, including diabetes or heart disease. HealthDay News — One in 8 adults (12%) say they have ever taken a glucagon-like peptide-1 receptor ...